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INTRODUCTION
Post-operative adhesion formation is still a major
complication of open laparotomy surgery or operative
laparoscopy and a contributing factor that cause in-
fertility, small bowel obstruction, ectopic pregnancy,
abdominal or pelvic pain and increasing difficulty
when reoperation is performed.1 Adhesion actually re-
sults as a natural consequence of surgical trauma and
healing. Operative injury will cascade several reac-
tions that trigger adhesion formation through inflam-
mation process, reactive oxygen species (ROS) which
results in formation of fibrinous exudate.2-4 The use
of laparoscopy is less adhesiogenic than laparotomy,
this was demonstrated by Dwight Chen5 when com-
pared laparoscopy vs laparotomy in the porcine model
to evaluate the adhesion formation. The result were
significantly higher adhesion formation was observed
in the laparotomy group than in the laparoscopic
group. But a study done by Binda4 demonstrated the
use of CO2 gas for the pneumoperitoneum during la-
paroscopy was cofactor in adhesion formation itself.
Based on these studies, whether the surgical proce-
dures are, it is important to consider the prevention
of adhesion. Nowadays, there are many methods that
can be used, which are: modification of surgical tech-
nique, anti-inflammatory agents, peritoneal instillates,
and surgical adhesion barriers. This article shows the
review of methods mentioned above.
Abstract
Objective: To know the modalities used for prevention of adhe-
sion formation in operative laparoscopy.
Method: Literature study.
Results: Methods of prevention of adhesion in laparoscopy in-
clude: modification of surgical technique, anti-inflammatory agents,
peritoneal instillates and barrier adjuvants. Modification of surgical
techniques such as adherence to basic principles of microsurgery,
the use of electrothermal bipolar vessel sealer, liberal irigation of
the abdominal cavity and instillation of a large amount of Ringer’s
lactate at the completion of the procedure. This technique alone,
eventhough seems effective, is insufficient. The anti-inflammatory
agents used are the NSAIDs, corticosteroids, antihistamines, pro-
gestogens, GnRH agonists and calcium channel blocker. But none
of them demonstrated to be significantly effective. Barrier adjuvants
consist of: oxidized regenerated cellulose (ORC) and expanded po-
lytetrafluoroethylene (ePTFE) and peritoneal instillates are the crys-
talloids, icodextrin, hyaluronic acid (HA), solution of HA, viscoe-
lastic gel, hydrogel, and fibrin sealent. There is insufficient evidence
data regarding the methods above for the prevention of adhesioge-
nesis in laparoscopy. But one study evaluating the use of viscoelas-
tic gel did significantly reduce adnexal adhesion in laparoscopy.
Conclusion: Laparoscopy does not trully eliminate the adhesio-
genesis problem. No single therapy is effective for prevention of ad-
hesion formation. The multimodal methods shall be used to increase
the successful rate in adhesion prevention.
[Indones J Obstet Gynecol 2010; 34-4: 204-7]
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Abstrak
Tujuan: Untuk mengetahui modalitas dalam mencegah pemben-
tukan perlengketan pada laparoskopi operatif.
Metode: Studi literatur.
Hasil: Metode pencegahan perlekatan pada laparoskopi terma-
suk: modifikasi teknik bedah, anti-inflamasi, penggunaan cairan ke
dalam rongga peritoneum dan barrier adjuvan. Modifikasi teknik
bedah seperti aplikasi prinsip-prinsip dasar bedah mikro, penggu-
naan kauter elektro termal bipolar, irigasi dari rongga peritoneum
dengan sejumlah besar ringer laktat pada tahap penyelesaian pro-
sedur. Teknik ini saja, meskipun tampaknya efektif, tidak cukup.
Anti-inflamasi yang digunakan adalah NSAID, kortikosteroid, anti-
histamin, progestogen, agonis GnRH dan penghambat saluran kal-
sium. Tapi tak satu pun dari mereka terbukti efektif secara signifi-
kan. Barrier adjuvan terdiri dari oxidized regenerated cellulose
(ORC) serta expanded polytetrafluoroethylene (ePTFE) sedangkan
cairan untuk rongga peritoneum adalah kristaloid, icodextrin, asam
hialuronat (HA), larutan HA, gel viskoelastik, hidrogel, dan silen
fibrin. Namun data-data yang ada mengenai metode di atas tidak
cukup membuktikan dapat mencegah perlengketan pascalaparosk-
opi. Tapi satu studi mengevaluasi penggunaan gel vis-koelastik se-
cara signifikan dapat mengurangi perlengketan pada adneksa di la-
paroskopi.
Kesimpulan: Laparoskopi tidak menghilangkan masalah terja-
dinya perlengketan pascaoperasi. Tidak ada terapi tunggal yang
efektif untuk mencegah pembentukan perlengketan. Pendekatan se-
cara multimodalitas harus digunakan untuk meningkatkan tingkat
keberhasilan dalam pencegahan perlengketan.
[Maj Obstet Ginekol Indones 2010; 34-4: 204-7]
Kata kunci: laparoskopi, perlengketan, bedah mikro, anti-infla-
masi, instilasi rongga peritoneum, barrier adjuvan
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PATHOGENESIS OF ADHESION
Role of inflammation process
Surgical trauma or injury to the peritoneal tissue will
triggers the breakdown of stromal mast cells and in-
creased vascular permeability. Disruption of stromal
cells will release histamine and kinin which will fur-
ther increase the vascular permeability and induce the
release of vasoactive substances and inflammatory
exudates.1 Increased of vascular permeability results
in deposition of fibrin, leucocytes and macrophage
which will release pro-inflammatory cytokines. In the
physiologic process, fibrin-riched blood clot will be
degraded by the fibrinolytic activity, which is Plas-
minogen-Activiting activity (PAA) in the mesotheli-
um, resulting in the repair of damaged tissue (meso-
thelial regeneration). In the presence of pro-inflamm-
atory cytokines, the PAA is inhibited by the plas-
minogen activity inhibitor (PAI)-1 and 2 resulting in
decreased fibrinolytic activity and formation of fi-
brous adhesion.1,2,6 Summary of the process can be
found on Figure 1.
Among the cytokines which take part in the adhe-
siogenesis, formation of blood vessels and the remo-
delling process are the transforming-growth-factors
(TGF)-β and the vascular endothelial growth factors
(VEGF).6
Role of reactive oxygen species (ROS) and hyper-
oxia condition
Laparoscopy, eventhough claimed to be less adhesio-
genic, is also a cofactor of adhesiogenesis. The use
of CO2 gas to make the pneumoperitoneum (insuffla-
tion/deflation process) has altered the mesothelial
cells and peritoneal fluid that will result in ischaemia
and reperfusion injury.4 This injury will generate ROS
and decrease ROS scavengers, such as catalases, su-
peroxide dismutase (SOD) and glutathione peroxidase
(GSH-Px). A study by Binda3 using laparoscopy in
mouse demonstrated that CO2 gas will enhance the
adhesion process. In the study, he developed three
models in which different types of insufflation gas
are used: the hypoxic model, in which pure CO2 is
used, corresponds to a traditional laparoscopy; the
normoxia model, in which 3% oxygen is added to the
pneumoperitoneum; and the hyperoxia model, in
which 12% oxygen is added to the pneumoperi-
toneum, and which mimics open surgery because tis-
sues are in contact with the high oxygen concentration
of air. During these studies, he demonstrated that ad-
hesion formation is increased using pure CO2 pneu-
moperitoneum and when more than 10% oxygen is
added to the pneumoperitoneum, in comparison with
a CO2 pneumoperitoneum with 3 - 4% of oxygen.
PREVENTION OF ADHESION FORMATION
Methods of prevention of adhesion include: modifica-
tion of surgical technique, minimizing tissue trauma,
anti-inflammatory agents, peritoneal instillates and ap-
plying pharmacological and/or barrier adjuvants.
Surgical technique
Laparoscopy is more superior than laparotomy be-
cause laparoscopy takes minimal access into the ab-
dominal cavity by reducing peritoneal injury, avoid-
ing incision through highly vascularized anatomical
structures, reducing manipulation of structures distant
from the operative site, and with its magnified view
enables greater handling and more precise dissection
of anatomical structures at the operative site, thus
contributing to minimize the degree of tissue trauma.7
Besides that, the use of basic principles of micro-
surgery, liberal irrigation of the abdominal cavity and
instillation of a large amount of Ringer’s Lactate at
the completion of the procedure will reduce the adhe-
siogenesis process.8
The use of developed instruments like electrother-
mal bipolar vessel sealer is associated with a reduced
post-operative adhesion formation in comparison with
ultrasonically activated scalpel and monopolar elec-
trocautery. For surgical technique, in advanced endo-
metriosis, temporary ovarian suspension is a techni-
que for preventing periovarian post-operative adhesi-
ons. In case of laparoscopic myomectomy, subserous
sutures are associated with significantly lower adhe-
sion rate and higher pregnancy rate in comparison
with interrupted ’figure 8’ sutures.9Figure 1. Pathophysiology of adhesion formation.1
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Anti-inflammatory agents
The anti-inflammatory agents used for prevention of
adhesion formation are the NSAIDs, corticosteroids,
antihistamines, progestogens, GnRH agonists and cal-
cium channel blocker. NSAIDs, corticosteroids and
anti-histamines have shown to be effective in prevent-
ing adhesion formation in several animal strudies,
however there is no significant evidence from any
published study to recommend their use in humans.1,7
Progestogens have shown to be effective in prevent-
ing adhesion in laparotomy surgery but no data found
in the setting of laparoscopy.7 GnRH agonist works
through inhibition of neoangiogenesis, improving fi-
brinolytic reactivity, and reduction of the degree of
inflammation. Studies demonstrated that GnRH de-
crease adhesion formation in animal model. At pre-
sent, no studies evaluate the use of GnRH in preven-
ting adhesion formation in human laparoscopy.7 Stu-
dies demonstrated that calcium-channel blocker is ef-
fective in reducing adhesion formation in animal mo-
dels but never been followed with studies in human.7
Peritoneal instillates and barrier adjuvant
Another methods for preventing the adhesion forma-
tion is using peritoneal instillates and barrier adjuvant.
This scientific rationale behind the basic process is
mechanical separation of peritoneal surfaces of the
pelvic organs during the early days of the healing
process. Barrier adjuvants consist of: oxidized regen-
erated cellulose (ORC) and expanded polytetrafluo-
roethylene (ePTFE). Peritoneal instillates consist of:
crystalloids, icodextrin, hyaluronic acid (HA), solu-
tion of HA, viscoelastic gel, hydrogel, and fibrin sea-
lent.7
Oxidized regenerated cellulose reduces adhesion
formation by transforming into gelatinous mass co-
vering the damaged peritoneum and forming a barrier
physically separating adjacent raw peritoneal surfa-
ces. The use of ORC is associated with reduced inci-
dence of both de novo and reformed adhesions. It is
essential that complete hemostasis is achieved before
ORC is placed on the peritoneal surface, as the pres-
ence of intraperitoneal blood negates any beneficial
effect.1,7
Expanded polytetrafluoroethylene is a nonabsor-
bable adhesion barrier produced in thin sheets. This
barrier has also been shown to decrease the severity,
extension and incidence of adhesion. But its limits are
this barrier must be sewn in place and should be re-
moved at subsequent surgery so it is not applicable
in laparoscopy.1,7
Crystalloid is the most popular and economic agent
used for ahesion prevention. Instillation of large vol-
ume of crystalloid into the peritoneal cavity causes
the ’hydroflotation’ effect. However, because of the
rapid absorption rate of the peritoneum, the crystal-
loid fluid will likely to assimilate into the vascular
system within 24 - 48 hour so it will not reduce the
formation of adhesion.10
Icodextrin is an a-1,4 glucose polymer of high mo-
lecular weight, which is rapidly metabolized to glu-
cose by the a-amylase in the systemic circulation, but
is absorbed only slowly from the peritoneal cavity.
The 4% solution of icodextrin, having a longer peri-
toneal residence time (≥ 4 days) than crystalloid so-
lutions, has the potential to significantly reduce post-
surgical adhesion formation by means of a prolonged
hydroflatation. Preclinical studies of icodextrin in ani-
mal model demonstrated a reduction in de-novo ad-
hesion formation. But currently, there is no sufficient
evidence in prevention of adhesion formation laparo-
scopy.10
Hyaluronic acid is a naturally occurring glycosami-
noglycan and a major component of the extracellular
matrix, including connective tissue, skin, cartilage and
vitreous and synovial fluids. This polymer is biocom-
patible, nonimmunogenic, non-toxic and naturally
bioabsorbable. Intraperitoneal instillation coats sero-
sal surface, minimizes serosal dessication and reduces
adhesion formation. However, its use after tissue in-
jury is ineffective.11,12
Solution of HA is a liquid composed of 0.4% so-
dium hyaluronate (hyaluronic acid) in phosphate buff-
ered saline, is applied intraoperatively, prior to dis-
section, to protect peritoneal surfaces from indirect
surgical trauma or post-operatively to separate sur-
faces after they are traumatized. In animal models,
this solution reduced serosal damage, inflammation
and post-surgical adhesions. In human, no studies
evaluating the role of solution of HA in preventing
adhesion following laparoscopic gynecological pro-
cedures are available in the literature.13
Viscoelastic gel is a gel composed of polyethylene
oxide and carboxymethylcellulose stabilized by cal-
cium chloride specifically formulated for laparoscopic
application, with tissue adherence and persistence suf-
ficient to prevent adhesion formation. Studies done
by Lundorf et al14 demonstrated that viscoelastic gel
did significantly reduce adnexal adhesions in patients
undergoing gynaecological laparoscopic surgery.
Hydrogel is two synthetic liquid precursors that,
when mixed, rapidly cross-link to form a solid, flex-
ible, absorbable hydrogel. The solid polymer acts as
an adhesion barrier and it can be easily applied by
laparoscopy. The currently available evidence does
not support the use of hydrogel either in decreasing
the extent of adhesion or in reducing the proportion
of women with adhesions.7
Fibrin sealant is a two-component substance that
can be applied as a liquid solution to the tissue. The
mixture of the two substances becomes a highly po-
lymerized solid fibrin film. Clinical data regarding the
use of fibrin sealant in prevention of adhesions are
limited.7
CONCLUSION
Adhesion is still a major contributor for infertility,
small bowel obstruction, ectopic gestation, abdominal
or pelvic pain and difficulty when reoperation. La-
parotomy is more likely to be adhesiogenic than la-
paroscopy. But, eventhough laparoscopy claimed to
be less adhesiogenic, however it does not trully elimi-
nate the problem. Therefore, many modalities have
been developed to at least minimize this adverse
event, which are: modification of surgical technique,
anti-inflammatory agents, peritoneal instillates, and
surgical adhesion barriers.
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Many clinical reviews show that there is still no
single therapy is proven highly effective for preven-
tion of adhesion formation. Although some of it show
promising result. Perhaps in the future, the multimo-
dal or combined methods shall be used to increase
the successful rate in adhesion prevention. Further re-
search on this subject shall be conducted.
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